Sildenafil Tablet, Film Coated
Product Images NDC 50090-7977

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-7977). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907977)

Sildenafil 50 mg film-coated tablets label showing the active ingredient Sildenafil Citrate USP equivalent to 50 mg Sildenafil. The label includes storage instructions to store at 68 to 77 degrees Fahrenheit and indicates a package size of 10 tablets. The product is labeled by A-S Medication Solutions, Libertyville, Illinois, with NDC 50090-7977-0.*

FDA Label Image

Fig-1 (Sildenafil Fig 1)

A line graph comparing the effect of Sildenafil 50 mg with placebo over time, showing changes in a measured variable in micrograms per milligram (µg/mg) across several hours post-dose.*

FDA Label Image

Fig-2 (Sildenafil Fig 2)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing blood pressure changes over time post-dose. The chart compares two groups: Placebo and Sildenafil 25 mg, with time points on the x-axis and systolic blood pressure change (mm Hg) on the y-axis. The Sildenafil group is represented by a blue line, and placebo by a black line.*

FDA Label Image

Fig-3 (Sildenafil Fig 3)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing time points on the x-axis and blood pressure change in mmHg on the y-axis. It compares placebo and Sildenafil 50 mg, illustrating the mean changes over several time intervals after dosing.*

FDA Label Image

Fig-4 (Sildenafil Fig 4)

A line graph depicting the mean standing systolic blood pressure change from baseline over time following dosing. The x-axis represents time after dosing in hours, and the y-axis shows the change in systolic blood pressure in mmHg. Three data series are shown, corresponding to dosing with Sildenafil 100 mg, Desmopressin, and Placebo.*

FDA Label Image

Fig-5 (Sildenafil Fig 5)

A line graph comparing plasma concentration over time post-dose between Sildenafil 50 mg/1 film-coated tablet and a commercial tablet. The graph shows plasma concentration (y-axis) versus time (x-axis) up to 24 hours after dosing, illustrating pharmacokinetic profiles.*

FDA Label Image

Sildenafil-fig-6-part-1.jpg (Sildenafil Fig 6 Part 1)

A bar chart titled 'Effect of Sildenafil on Maintenance of Erection by Baseline Score' showing the number of patients at endpoint on the vertical axis and baseline score on the horizontal axis. Multiple bars per baseline score indicate different categories or levels, illustrating the distribution of patients across scores with Sildenafil treatment.*

FDA Label Image

Sildenafil-fig-6-part-2.jpg (Sildenafil Fig 6 Part 2)

A bar chart titled 'Effect of Placebo on Maintenance of Erection by Baseline Score' showing the percentage of patients at endpoint across baseline scores from 0 to 5. The chart uses grouped bars to represent different categories or time points labeled 0 to 5, with percentages ranging up to 80% on the vertical axis.*

FDA Label Image

Fig-7 (Sildenafil Fig 7)

A vertical bar chart illustrating the percentage of patients reporting improvement across four treatment groups. The groups include Placebo, Sildenafil Citrate 25 mg, Sildenafil Citrate 50 mg, and Sildenafil Citrate 100 mg, with improvement percentages increasing progressively from placebo to the highest dose.*

FDA Label Image

Sildenafil-structure.jpg (Sildenafil Structure)

Chemical structure of sildenafil showing its molecular framework with labeled functional groups and distinct chemical bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.